The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Moderna, the second COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency (EMA) and is endorsed […]
European Commission authorises first safe and effective vaccine against COVID-19
The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by BioNTech and Pfizer, making it the first COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency […]
Waging war against SARS-CoV-2 with Europe’s most powerful supercomputers
Searching for new COVID-19 treatments, an EU-funded project conducted a supercomputing experiment to study the interaction of over 70 billion antiviral molecules with SARS-CoV-2 proteins. A huge molecular computation experiment was recently conducted to identify new treatments against the SARS-CoV-2 virus. Run by the EU-funded EXSCALATE4CoV project, the experiment is believed to be the most […]
Commission approves contract with Moderna to ensure access to a potential vaccine
The European Commission approved a sixth contract under the EU Vaccines Strategy, this time with the pharmaceutical company Moderna. The contract provides for the initial purchase of 80 million doses on behalf of all EU Member States, plus an option to request up to a further 80 million doses, to be supplied once a vaccine […]